Metraipolis › archive › dc_dbd85ca796de

Cognitive outcomes after tadalafil treatment in patients with cerebral small vessel disease: ETLAS-2 sub-study — Europe PMC PMID:41332889

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41332889
DOI
10.1016/j.cccb.2025.100520
License (as archived)
solo-consultazione
Archived
2026-11-08T16:17:41.127Z
SHA-256 of the archived text
058375dc107704d0b2327e5880cfefb9c3e89fe1686aff82f36ff7662e680648
Stable URL of this page
https://metraipolis.com/documento/dc_dbd85ca796de

How to cite

Cognitive outcomes after tadalafil treatment in patients with cerebral small vessel disease: ETLAS-2 sub-study — Europe PMC PMID:41332889 — Europe PMC (en), https://europepmc.org/article/MED/41332889 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbd85ca796de (Metraipolis archive dc_dbd85ca796de, sha256 058375dc107704d0b2327e5880cfefb9c3e89fe1686aff82f36ff7662e680648)
BibTeX
@misc{dcdbd85ca796de,
  title = {Cognitive outcomes after tadalafil treatment in patients with cerebral small vessel disease: ETLAS-2 sub-study — Europe PMC PMID:41332889},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41332889},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbd85ca796de; sha256 058375dc107704d0b2327e5880cfefb9c3e89fe1686aff82f36ff7662e680648},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41332889. Agents can read the archived copy with the MCP tool read_document.